J. Michael Klatte, MD

Dr. J. Michael Klatte is a pediatric infectious disease specialist who helps care for babies, children, and teens with common and uncommon infections. From infancy through late adolescence, he focuses on preventing illness, finding the cause of infection, and choosing treatments that are safe and effective. Dr. Klatte takes time to explain what’s going on and what to expect, so families feel informed and reassured every step of the way.

Dr. Klatte is especially passionate about antibiotic stewardship - using the right medicine, for the right infection, for the right amount of time. He believes this approach protects children today while keeping antibiotics effective for the future. Dr. Klatte values partnership with families and often reminds parents: you know your child best, and your concerns matter. Outside of work, he enjoys long‑distance running on the scenic recreational trails around the Dayton area.

awards and honors

• Dayton Magazine "Best Doctors - Infectious Disease", 2023 and 2024
• Baystate Children's Hospital Faculty Evidence-Based Medicine Award, 2020
• Baystate Children's Hospital Outstanding Faculty Teacher of the Year, 2015

organizations

• American Academy of Pediatrics
• Infectious Diseases Society of America
• Pediatric Infectious Diseases Society

publications and presentations

• Mock M, Morris D, Foley J, Mahabee M, Klatte JM, Williams B, Robie D. Leveraging Quality Improvement Tools to Improve Administration of First-line Surgical Antibiotic Prophylaxis in Patients Labeled as Penicillin Allergic. Pediatr Qual Saf. 2025; 10(1): e794.
• Burkhardt MC, Winter K, Alter SJ, Klatte JM. A COVID-19 Primer for Primary Care Clinicians. Curr Probl Pediatr Adolesc Health Care. 2022; 52(4): 101180.
• Klatte JM, Harrison CJ, Pate B, Queen MA, Neuhart J, Jackson MA, Selvarangan R. Maternal Parechovirus A (PeV-A) Shedding, Serostatus, and the Risk of Central Nervous System PeV-A Infections in Infants. J Clin Virol. 2021; 142: 104939
• Klatte JM. Pediatric Antimicrobial Stewardship Programs: Current Perspectives. Pediatric Health Med Ther. 2020; 11: 245-255.
• Klatte JM, Knee A, Szczerba F, Horton ER, Kopcza K, Fisher DJ. Identification of High-Yield Targets for Antimicrobial Stewardship Program Efforts Within a Nonfreestanding Children’s Hospital. Hosp Pediatr. 2019; 9(5): 355-364.
• Klatte JM, Kopcza K, Knee A, Horton ER, Housman E, Fisher DJ. Implementation and Impact of an Antimicrobial Stewardship Program at a Non-freestanding Children’s Hospital. J Pediatr Pharmacol Ther. 2018; 23 (2): 84-91.
• Klatte JM, Selvarangan R, Jackson MA, Myers AL. Reducing Overutilization of Testing for Clostridium difficile infection in a Pediatric Hospital System: A Quality Improvement Initiative. Hosp Pediatr. 2016; 6 (1): 9-14.
• Torres-Torres S, Myers AL, Klatte JM, Rhoden EE, Oberste MS, Collett MS, McCulloh RJ. First Use of Investigational Antiviral Drug Pocapavir (V-073) for Treating Neonatal Enteroviral Sepsis. Pediatr Infect Dis J. 2015; 34 (1): 52-4.
• Klatte JM, Newland JG, Jackson MA. Incidence, Classification, and Risk Stratification for Candida Central Line-Associated Bloodstream Infections in Pediatric Patients at a Tertiary Children’s Hospital from 2000-2010. Infect Control Hosp Epidemiol. 2013; 34 (12): 1266-71.
• Klatte JM, Dastjerdi M, Clark K, Harrison CJ, Grigorian F, Stahl ED. Hyperacute Infectious Keratitis with Plesiomonas shigelloides Following Traumatic Lamellar Corneal Laceration. Pediatr Infect Dis J. 2012; 31 (11): 1200-1.
• Klatte JM, Myers AL, Livingston RA, Jackson MA. Pediatric Physicians’ Knowledge, Attitudes and Beliefs Regarding Clostridium difficile-associated Disease (CDAD) Prevention, Testing, and Treatment. Am J Infect Control. 2012; 40 (6): 577.
• Klatte JM, Clarridge III JE, Bratcher D, Selvarangan R. A Longitudinal Case Series Description of Meningitis Due to Streptococcus gallolyticus subspecies pasteurianus in Infants. J Clin Microbiol. 2012; 50 (1): 57-60.